Pharma Equity Group Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Thomas Selsø
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 0.2% |
| Management average tenure | no data |
| Board average tenure | 1.3yrs |
Recent management updates
CEO
Thomas Selsø (50 yo)
no data
Tenure
Mr. Thomas Kaas Sels? serves as Chief Executive Officer at Pharma Equity Group A/S (formerly known as Reponex Pharmaceuticals ApS). and served as its Chief Financial Officer.He has experience as CFO of va...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Scientific Advisor | no data | no data | no data | |
| Scientific Advisor | no data | no data | no data | |
| Scientific Advisor | no data | no data | no data | |
| Chairman of the Board | 1.3yrs | no data | 0.12% DKK 233.1k | |
| Vice Chairman of the Board | less than a year | no data | no data | |
| Director | 1.3yrs | no data | 2.09% DKK 4.0m | |
| Independent Director | 1.3yrs | no data | no data | |
| Independent Director | less than a year | no data | no data |
1.3yrs
Average Tenure
62yo
Average Age
Experienced Board: PEG's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.